Alamin SE 410mg/100mg/290mg/130mg Infusion
Marketer
Albert David Ltd
Salt Composition
L-Leucine (410mg) + L-Isoleucine (100mg) + Phenylalanine (290mg) + L-Histidine Hydrochloride (130mg)
Overview Alamin SE 410mg/100mg/290mg/130mg Infusion
Alamin SE Infusion (410 mg/100 mg/290 mg/130 mg) is a prescription-only intravenous solution. This nutritional supplement combination addresses nutritional and mineral deficits, promoting optimal bodily growth and function. Administered solely by a healthcare provider, self-injection is strictly prohibited. Report any allergies to this medication to your physician immediately. Injection site reactions, including redness, swelling, or pain, may occur; these typically resolve spontaneously, but persistent symptoms warrant medical attention. Disclose any pre-existing conditions or concurrent medications to your doctor before treatment.
Uses of Alamin SE 410mg/100mg/290mg/130mg Infusion
Inadequate nutrient intake
Major Benefits of Alamin SE 410mg/100mg/290mg/130mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Alamin SE 410mg/100mg/290mg/130mg Infusion:
- No common side effects seen
How to use Alamin SE 410mg/100mg/290mg/130mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Alamin SE 410mg/100mg/290mg/130mg Infusion works:
Alamin SE Infusion (410 mg/100 mg/290 mg/130 mg) provides a blend of four essential nutritional components—L-leucine, L-isoleucine, phenylalanine, and L-histidine hydrochloride—to restore vital nutrient levels within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Alamin SE 410 mg/100 mg/290 mg/130 mg Infusion may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The intravenous formulation of Alamin SE (410 mg/100 mg/290 mg/130 mg) poses established risks to a fetus and should not be administered during pregnancy. Exceptions may be made in critical circumstances where the potential benefits outweigh the known hazards, at the sole discretion of a physician. Always seek medical advice.
Breast feedingCAUTION
Administering Alamin SE 410 mg/100 mg/290 mg/130 mg Infusion to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingCONSULT YOUR DOCTOR
The effect of Alamin SE 410 mg/100 mg/290 mg/130 mg Infusion on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with impaired kidney function should receive Alamin SE 410 mg/100 mg/290 mg/130 mg Infusion cautiously. Dosage modification of Alamin SE 410 mg/100 mg/290 mg/130 mg Infusion might be necessary; physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should receive Alamin SE 410 mg/100 mg/290 mg/130 mg Infusion cautiously, with potential dosage modification as determined by their physician. Medical advice is recommended.
What if you forget to take Alamin SE 410mg/100mg/290mg/130mg Infusion :
NA
Facts to Know About Alamin SE 410mg/100mg/290mg/130mg Infusion
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Essential Vitamins, Minerals, and Nutrients |
3,018 People bought this recently